Bioxyne Stock

Bioxyne EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Bioxyne (BXN.AX) as of Aug 1, 2026 is 24.09. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -26.44 — a change of -191.12% (higher).

EV/FCF

24.09

YoY

-191.12%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Bioxyne is 2026 24.09 . EV/FCF (Enterprise Value to Free Cash Flow) of Bioxyne was 2025 -26.44 . It decreases by -191.12% higher compared to the previous year.
Access this data via the Eulerpool API

Bioxyne Stock analysis

What does Bioxyne do? Bioxyne Ltd is an Australian biotechnology company that was founded in 2000. Bioxyne's business model focuses on the discovery, development, and marketing of innovative, turnkey biological products and services to improve consumers' health and well-being. Bioxyne has four different business divisions: natural products, health and wellness products, veterinary products, and contract research services. In the natural products division, Bioxyne offers a portfolio of products based on natural ingredients, such as probiotics, superfood powders, herbal extracts, and dietary supplements. These products are designed to strengthen the immune system, promote gut health and digestion, and support a healthy lifestyle. Bioxyne's health and wellness product division offers a wide range of innovative products aimed at improving the health and well-being of people, such as vitamins, dietary supplements, skincare products, and anti-aging products. Bioxyne utilizes the latest biotechnological research to manufacture these products tailored to the needs of customers worldwide. The veterinary product division of Bioxyne is dedicated to improving the health and well-being of pets, livestock, and other animals. Bioxyne offers a wide range of animal health products, including dietary supplements to enhance immune system and skin and hair health, as well as products supporting digestion, metabolism, and cognitive functions in animals. Bioxyne's contract research service division specializes in providing customized and turnkey biological services and products to customers in the pharmaceutical industry, food industry, and veterinary medicine. Bioxyne has an experienced team of scientists and researchers specialized in conducting research and development services in the field of biotechnology. Some of Bioxyne's notable products include the probiotic Nuflora, used to support and improve gut health, the natural dietary supplement Ceramosides, which has strong anti-aging effects due to its formula, and the superfood powder blend Health 365, which contains all the essential nutrients needed to support a healthy lifestyle. Overall, Bioxyne offers a wide range of biotechnological products and services tailored to the needs of customers worldwide. The company is committed to incorporating the latest biotechnological advancements into its products and offering its customers innovative and high-quality solutions to improve health and well-being. Bioxyne is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioxyne stock

EV/FCF (Enterprise Value to Free Cash Flow) of Bioxyne is 24.09 in 2026.

Access this data via the Eulerpool API

Valuation — Bioxyne

All Key Metrics — Bioxyne